BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3377456)

  • 21. Susceptibility of Neisseria gonorrhoeae to ceftizoxime in vitro and in vivo.
    Korting HC; Neubert U
    Chemotherapy; 1984; 30(5):322-7. PubMed ID: 6092006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of gonorrhoea with cefotiam: activity in vitro and clinical results of a 1-gram single-dose regimen.
    Korting HC; Neubert U
    Dermatologica; 1985; 171(4):264-8. PubMed ID: 3935494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of ceftriaxone and spectinomycin for treatment of uncomplicated gonorrhoea in men.
    Handsfield HH; Murphy VL
    Lancet; 1983 Jul; 2(8341):67-70. PubMed ID: 6134959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection.
    Plourde PJ; Tyndall M; Agoki E; Ombette J; Slaney LA; D'Costa LJ; Ndinya-Achola JO; Plummer FA
    J Infect Dis; 1992 Oct; 166(4):919-22. PubMed ID: 1527431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of uncomplicated gonorrhea with single doses of 200 mg cefixime.
    Verdon MS; Douglas JM; Wiggins SD; Handsfield HH
    Sex Transm Dis; 1993; 20(5):290-3. PubMed ID: 8235928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients.
    Maesen FP; Davies BI; van den Bergh JJ; Gubbelmans HL; Meek JC; Geraedts WH
    J Antimicrob Chemother; 1990 Mar; 25(3):413-22. PubMed ID: 2187013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized comparison of cefotaxime and ceftriaxone in patients with uncomplicated gonorrhea.
    Jones RB; Mogabgab WJ; McCormack WM; Wendel GD
    Clin Ther; 1991; 13(5):550-6. PubMed ID: 1799912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single dose enoxacin for the treatment of uncomplicated urogenital gonorrhea.
    Albrecht LM; Rybak MJ; Schubiner HH; Weiner LM
    Sex Transm Dis; 1989; 16(2):114-7. PubMed ID: 2500718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma, cantharides blister fluid, and suction blister fluid levels of ceftizoxime after single intramuscular application for gonorrhea.
    Korting HC; Schäfer-Korting M; Haag R; Mutschler E
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):218-20. PubMed ID: 6325353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of uncomplicated infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae.
    Klepser ME; Quintiliani R; Nightingale CH
    Conn Med; 1994 Aug; 58(8):489-94. PubMed ID: 7924316
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral cefixime versus intramuscular ceftriaxone in patients with uncomplicated gonococcal infections.
    Portilla I; Lutz B; Montalvo M; Mogabgab WJ
    Sex Transm Dis; 1992; 19(2):94-8. PubMed ID: 1534422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of cefotetan in uncomplicated gonorrhea.
    Korting HC; Abeck D; Neubert U
    Dermatologica; 1986; 173(5):237-44. PubMed ID: 3100355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single dose of cefodizime completely eradicated multidrug-resistant strain of Neisseria gonorrhoeae in urethritis and uterine cervicitis.
    Matsumoto T; Muratani T; Takahashi K; Ando Y; Sato Y; Kurashima M; Yokoo D; Ikuyama T; Shimokawa H; Yanai S
    J Infect Chemother; 2006 Apr; 12(2):97-9. PubMed ID: 16648949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of ceftriaxone and spectinomycin for treatment of pharyngeal and anorectal gonorrhea.
    Judson FN; Ehret JM; Handsfield HH
    JAMA; 1985 Mar; 253(10):1417-9. PubMed ID: 3155806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of ceftriaxone and aqueous procaine penicillin G in the treatment of uncomplicated gonorrhea in women.
    Judson FN; Ehret JM; Root CJ
    Antimicrob Agents Chemother; 1983 Feb; 23(2):218-20. PubMed ID: 6301364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ceftriaxone as a single-dose treatment for male gonococcal urethritis].
    Urabe S; Shigematsu S
    Jpn J Antibiot; 1984 Nov; 37(11):2169-73. PubMed ID: 6098709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of gonorrhea: comparison of cefotaxime and penicillin.
    Simpson ML; Khan MY; Siddiqui Y; Gruninger RP; Wigren DI
    Antimicrob Agents Chemother; 1981 May; 19(5):798-800. PubMed ID: 6271049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical safety profile of cefodizime.
    Perianu MR
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():127-34. PubMed ID: 2074247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study.
    Hook EW; Golden MR; Taylor SN; Henry E; Tseng C; Workowski KA; Swerdlow J; Nenninger A; Cammarata S
    Sex Transm Dis; 2019 May; 46(5):279-286. PubMed ID: 30985632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single 1 g dose of cefotaxime in the treatment of infections due to penicillinase-producing strains of Neisseria gonorrhoeae.
    de Koning GA; Tio D; van den Hoek JA; van Klingeren B
    Br J Vener Dis; 1983 Apr; 59(2):100-2. PubMed ID: 6299449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.